Cargando…
HBK-15, a Multimodal Compound, Showed an Anxiolytic-Like Effect in Rats
Anxiety is a common mental disorder, and its prevalence has lately increased because of the COVID-19 pandemic. Unfortunately, the available anxiolytics are often ineffective, and most possess addictive potential. Thus, searching for novel compounds is essential. In our previous studies, we selected...
Autores principales: | Lustyk, Klaudia, Sałaciak, Kinga, Jakubczyk, Magdalena, Jastrzębska-Więsek, Magdalena, Partyka, Anna, Wesołowska, Anna, Marona, Henryk, Pytka, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644393/ https://www.ncbi.nlm.nih.gov/pubmed/36350432 http://dx.doi.org/10.1007/s11064-022-03802-x |
Ejemplares similares
-
HBK-10, A Compound with α(1)-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats
por: Lustyk, Klaudia, et al.
Publicado: (2022) -
Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT(1A) and D(2) Receptors
por: Sałaciak, Kinga, et al.
Publicado: (2021) -
HBK-17, a 5-HT(1A) Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling
por: Pytka, Karolina, et al.
Publicado: (2018) -
Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT(1A) and 5-HT(7) Antagonists in Animal Models
por: Pytka, Karolina, et al.
Publicado: (2015) -
HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats
por: Pytka, Karolina, et al.
Publicado: (2016)